Skip to main content
SpringerLink
Log in

Gadolinium-containing contrast agents are associated with an increased risk of nephrogenic systemic fibrosis

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Kalajdzic T.Gadolinium-containing contrast agents and nephrogenic systemic fibrosis: update. Canadian Adverse Reaction Newsletter 17: 1-2, No. 4, Oct 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gadolinium-containing contrast agents are associated with an increased risk of nephrogenic systemic fibrosis. React. Wkly. 1175, 3 (2007). https://doi.org/10.2165/00128415-200711750-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711750-00008

Keywords

Search

Navigation